1. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359(9300):14-22. doi: 10.1016/S0140-6736(02)07273-2.
2. Dikareva EA, Makarenko EV, Pimanov SI. Otsenka riska razvitiya gastropatii, indutsirovannoi priemom nesteroidnykh protivovospalitel'nykh sredstv, na osnove mezhdunarodnykh soglasitel'nykh dokumentov. Vestn VGMU. 2015;14(5):39-45.
3. Pimanov SI, Dikareva EA, Makarenko EV. Kak umen'shit' gastrointestinal'nyi risk pri ispol'zovanii nesteroidnykh protivovospalitel'nykh preparatov. Consilium Medicum. 2014;16(2):95-99.
4. Pimanov SI, Semenova EV, Makarenko EV, Ruselik EA. Gastroduodenal'nye yazvy, vyzyvaemye antiagregantnymi i nesteroidnymi protivovospalitel'nymi preparatami: profilaktika po novym rekomendatsiyam. Consilium Medicum Gastroenterol. 2009;11(8):13-20.
5. Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs. Gastroenterology. 2018;154(3):500-514. doi: 10.1053/j.gastro.2017.10.049.